Aprogen Medicines Inc. (007460.KS)

KRW 748.0

(6.4%)

Market Cap (In KRW)

217.71 Billion

Revenue (In KRW)

150.57 Billion

Net Income (In KRW)

-55.61 Billion

Avg. Volume

2.35 Million

Currency
KRW
Country
Industrials
Open
-
Prev. Close
-
Day Range
-
Year Range
701.0-1894.0
PE
-
EPS
-
Beta Value
0.811
ISIN
KR7007460009
CUSIP
-
CIK
-
Shares
291068239.0
Earnings Annoncement
-

Company Profile

Sector
Industrials
Industry
Industrial - Machinery
CEO
Ki-Cheol Lim
Employee Count
-
Website
https://www.aprogen-kic.com
Ipo Date
2005-09-29
Details
Aprogen Medicines Inc. designs, manufactures, and maintains plant facilities for steelwork, petrochemistry, shipbuilding, power plant, and LNG base industries in South Korea. The company also offers thermal and cold spray services; and clad rolls, clad plates, wear plates, clad pipes and fittings, and plasma transferred arcs. In addition, it provides Nukon system, a special heat-preservation system that keeps the pipe facility of the internal equipment of the containment building working safely in the pressurized water reactor power plant; foamglas, a cellular glass insulation product; and fireproof insulation works in the POSCO furnaces and boilers. The company was formerly known as Aprogen KIC Inc. and changed its name to Aprogen Medicines Inc. April 2021. Aprogen Medicines Inc. was founded in 1971 and is based in Seongnam-si, South Korea.